Back to Results
First PageMeta Content
Oncology / Organofluorides / Medullary thyroid cancer / Cabozantinib / Vandetanib / Thyroid neoplasm / Multiple endocrine neoplasia / End point of clinical trials / Metastasis / Medicine / Thyroid cancer / Chemistry


cabozantinib 20mg and 80mg hard capsules (Cometriq®) Swedish Orphan Biovitrum Ltd. SMC No[removed]February 2015
Add to Reading List

Open Document

File Size: 199,18 KB

Share Result on Facebook

Company

Swedish Orphan Biovitrum Ltd. / Oncology Group / /

Continent

North America / Europe / /

Country

Scotland / /

Currency

GBP / /

IndustryTerm

anticancer medicinal products / treatment of this disease / above product / treatment for medullary thyroid cancer / treatment of inoperable progressive and symptomatic disease / treatment of medullary thyroid cancer / pharmaceutical / imaging / energy / /

MedicalCondition

radiographic disease / tumor / hereditary / hypertension / cancer / tumors / disease / metastasis / negative tumours / thyroid cancers / chronic / Solid Tumors / progressive disease / metastatic medullary thyroid carcinoma / hereditary cancer syndrome / nausea / tumour / coughing / mucositis / lack of appetite / Metastatic disease / abscesses / fatigue / thyroid carcinoma / medullary thyroid cancer / metastatic medullary thyroid cancer / diarrhea / neck pain / depression / thyroid cancer / metastases / rash / syndrome / tumours / /

MedicalTreatment

polychemotherapy / chemo / radiation therapy / chemotherapy / radiotherapy / drug therapy / surgery / /

Organization

Food and Drug Administration / FDA / NHS / /

Position

SMC website Vice Chairman / physician / Major / consultant / Co-operative / /

Technology

radiation / chemotherapy / /

URL

www.scottishmedicines.org.uk / /

SocialTag